The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEjf Investments Regulatory News (EJFI)

Share Price Information for Ejf Investments (EJFI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 95.50
Bid: 92.00
Ask: 99.00
Change: 0.00 (0.00%)
Spread: 7.00 (7.609%)
Open: 95.50
High: 95.50
Low: 95.50
Prev. Close: 95.50
EJFI Live PriceLast checked at -
EJF Investments is an Investment Trust

To generate attractive risk adjusted returns by investing in opportunities created by regulatory and structural changes impacting the financial services sector.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report to 31 December 2022

31 Mar 2023 07:00

RNS Number : 8561U
EJF Investments Ltd
31 March 2023
 

FOR IMMEDIATE RELEASE

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE REPUBLIC OF IRELAND), AUSTRALIA, CANADA, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DO SO.

31 March 2023

EJF Investments Ltd

Announcement of Final Results to 31 December 2022 and other matters

 

The Directors of EJF Investments Ltd ("EJFI" or the "Company") announce the release of the Annual Report and Audited Financial Statements for the year ended 31 December 2022.

The total net asset value ("NAV") return per ordinary share, inclusive of dividends, was 13.85% for the year ended 31 December 2022, which exceeded the Company's target return of 8% to 10% p.a. Dividends paid in respect of the year ended 31 December 2022, met the target dividend, and totalled 10.7 pence per ordinary share.

The Total Return of 13.85% was predominantly driven by regular interest accruals and payments in addition to some gains on the Company's Securitisation and Related Investments alongside strong mark-to-market gains on the MSRs investment. There continued to be no defaults in underlying collateral backing the Company's securitisation investments, which reflects the ongoing robust credit profiles of the Company's underlying targeted US bank and insurance exposures.

 

Highlights

· Total NAV return per ordinary share, inclusive of dividends, of 13.85% for the year ended 31 December 2022;

· Total NAV return per ordinary share, inclusive of dividends, of 93.38% since inception (exchange offer on 9 February 2017) to 31 December 2022;

· NAV as at 31 December 2022 of £112.5 million, 184 pence per ordinary share;

· Share price discount to NAV as at 31 December 2022 of 28.3%; and

· Dividend yield for the year ended 31 December 2022 based on dividends declared in respect of the period and share price at 31 December 2022 of 8.1%.

Post Annual Report Update

· Dividend of 2.675 pence per ordinary share paid in February 2023 in respect of the quarter ended 31 December 2022;

· Issuance of 2,277,046 new 2025 ZDP Shares at 119.78 pence per 2025 ZDP share, raising gross proceeds of approximately £2.7 million;

· NAV as at 28 February 2023 of £111.9 million or 183 pence per ordinary share, representing a year to date Total NAV return per ordinary share of 0.89%; and

· March 2023 has seen further significant turmoil in financial markets and certain segments of US and European banking sectors. On 29 March 2023, the Company issued a portfolio update detailing its exposure which can be accessed here (LINK).

The Company's Annual Report and Audited Financial Statements for the year ended 31 December 2022 is attached to this release and will be available on the Company's website (https://www.ejfi.com/investors/) shortly.

http://www.rns-pdf.londonstockexchange.com/rns/8561U_1-2023-3-30.pdf

 

Cessation of Placing Programme

The Company published a prospectus on 4 April 2022 which included a placing programme, due to end on 3 April 2023 (the "Placing Programme"). As less than a week of the Placing Programme remains unexpired, the Directors have decided to cease the Placing Programme with immediate effect.

 

 

 

 

 

ENQUIRIES

 

For the Investment Manager

EJF Investments Manager LLC

Peter Stage / Jay Ghatalia

pstage@ejfcap.com / jghatalia@ejfcap.com

+44 203 752 6775 / +44 203 752 6776

 

For the Company Secretary and Administrator

BNP Paribas S.A., Jersey Branch

jersey.bp2s.ejf.cosec@bnpparibas.com

+44 1534 813 967 / +44 1534 709 189

 

For the Broker

Liberum Capital Limited

Darren Vickers / Owen Matthews

+44 (0) 20 3100 2218 / +44 (0) 20 3100 2223

 

About EJF Investments Ltd

EJFI is a registered closed-ended limited liability company incorporated in Jersey under the Companies (Jersey) Law 1991, as amended, on 20 October 2016 with registered number 122353. The Company is regulated by the Jersey Financial Services Commission (the "JFSC"). The JFSC is protected by both the Collective Investment Funds (Jersey) Law 1988 and the Financial Services (Jersey) Law 1998, as amended, against liability arising from the discharge of its functions under such laws.

 

The JFSC has not reviewed or approved this announcement.

 

LEI: 549300XZYEQCLA1ZAT25

 

Investor information & warnings

 

The latest available information on the Company can be accessed via its website at www.ejfi.com

 

This communication has been issued by, and is the sole responsibility of, the Company and is for information purposes only. It is not, and is not intended to be an invitation, inducement, offer or solicitation to deal in the shares of the Company. The price and value of shares in the Company and the income from them may go down as well as up and investors may not get back the full amount invested on disposal of shares in the Company. An investment in the Company should be considered only as part of a balanced portfolio of which it should not form a disproportionate part. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSNKKBNKBKBKNN
Date   Source Headline
2nd May 20245:00 pmRNSDividend Declaration
2nd May 20247:00 amRNSDirectorate Change
30th Apr 20249:33 amRNSPortfolio Update
22nd Apr 20247:00 amRNSNet Asset Value and Portfolio Update
28th Mar 20247:00 amRNSAnnual Financial Report to 31 December 2023
21st Mar 20247:00 amRNSNet Asset Value and Portfolio Update
15th Mar 202410:40 amRNSResults Presentation for the YE 31 December 2023
21st Feb 20247:00 amRNSNET ASSET VALUE AND PORTFOLIO UPDATE
31st Jan 20243:00 pmRNSQUARTERLY REPORT
29th Jan 20244:57 pmRNSDividend Declaration - Replacement
29th Jan 20247:00 amRNSDividend Declaration
22nd Jan 20247:00 amRNSNet Asset Value and Portfolio Update
22nd Dec 20237:00 amRNSCorporate Update
20th Dec 20237:00 amRNSNet Asset Value and Portfolio Update
21st Nov 20237:00 amRNSNet Asset Value and Portfolio Update
2nd Nov 202310:43 amRNSQUARTERLY REPORT
25th Oct 20237:00 amRNSDividend Declaration
20th Oct 20237:00 amRNSNet Asset Value(s)
21st Sep 20237:00 amRNSNet Asset Value and Portfolio Update
8th Sep 20237:00 amRNSHalf-year Report
25th Aug 20234:32 pmRNSUpdate to composition of the Board of Directors
23rd Aug 20232:42 pmRNSNotice of Interim Results and Results Presentation
21st Aug 20237:00 amRNSNET ASSET VALUE AND PORTFOLIO UPDATE
1st Aug 20237:00 amRNSQUARTERLY REPORT
27th Jul 20235:34 pmRNSDividend Declaration
27th Jul 20237:00 amRNSPortfolio Update
20th Jul 20237:00 amRNSNet Asset Value and Portfolio Update
21st Jun 20237:00 amRNSNET ASSET VALUE AND PORTFOLIO UPDATE
21st Jun 20237:00 amRNSCORPORATE UPDATE
13th Jun 20234:07 pmRNSResult of AGM
25th May 20239:14 amRNSQuarterly Report
24th May 20237:00 amRNSNet Asset Value and Portfolio Update
18th May 20235:22 pmRNSNotice of AGM
26th Apr 20233:13 pmRNSDividend Declaration
25th Apr 20235:12 pmRNSDividend Declaration
25th Apr 20237:00 amRNSNet Asset Value(s)
5th Apr 20237:00 amRNSAppointment of Joint Corporate Broker
31st Mar 20237:00 amRNSAnnual Financial Report to 31 December 2022
29th Mar 20237:00 amRNSPortfolio Update
21st Mar 20237:00 amRNSNet Asset Value(s)
15th Mar 20237:00 amRNSPortfolio Update
27th Feb 20237:00 amRNSResults of Placing
21st Feb 20237:00 amRNSNet Asset Value(s)
20th Feb 20237:00 amRNSIssue of 2025 ZDP Shares under Placing Programme
26th Jan 20235:07 pmRNSDividend Declaration
23rd Jan 20237:00 amRNSNet Asset Value(s)
11th Jan 20232:10 pmRNSCorporate Update
21st Dec 20227:00 amRNSNet Asset Value(s)
21st Nov 20227:00 amRNSNet Asset Value(s)
16th Nov 20224:21 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.